These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2006-000228-14 Immunization of disease-free melanoma patients with different HLA-A2 peptides. not-yet-due
Ongoing 2006-000353-21 Comparison of the vasoreactivity and endogenous NO production between the left and right internal mammary 6 months after bypass surgery with the injection of substance P and exogenous nitric oxide. not-yet-due
Reported results 2006-001780-30 A PHASE II STUDY OF SU011248 IN PATIENTS WITH RECURRENT AND/OR METASTATIC SQUAMOUS HEAD AND NECK CARCINOMA. 2010-03-02 due-trials
Other 2006-003549-18 REDUCTION OF BONE MORBIDITY USING AN ORAL BISPHOSPHONATE IN FIBROUS DYSPLASIA OF BONE (PROFIDYS Trial) not-yet-due
Ongoing 2006-004635-30 A randomized multicentric phase II study of prolonged adjuvant Temozolomide or "stop and go" in glioblastoma patients : the PATSGO study. not-yet-due
Ongoing 2006-004830-34 TACROLIMUS AND PRETRANSPLANT HIGH-DOSE R-ATG INDUCTION VS TACROLIMUS MONOTHERAPY AS TOLEROGENIC IMMUNOSUPPRESSION IN ADULT LIVER TRANSPLANTATION.AN OPEN LABEL, RANDOMISED, PROSPECTIVE AND CONTROLLED T... not-yet-due
Ongoing, reported early 2006-005386-19 Cytokines and inflammatory proteins gene expression study in synovial biopsies from rheumatoid arthritis patients refractory to anti-TNF therapy treated with Rituximab not-yet-due
Ongoing, reported early 2007-001559-20 Steady-state pharmacokinetics of high dose acetaminophen inpost-op children. Rational use of N-acetyl cysteine for prevention of liver toxicity related to cumulative doses. not-yet-due
Ongoing 2007-002940-86 Sepsis, Endothelial function, and Lipids in critically ill patients with Liver Failure (SELLIFA). Nutritional sub-study : Randomized controlled trial comparing the tolerance on lipid metabolism and sa... not-yet-due
Completed, but no date, and reported results 2007-003023-20 TACROLIMUS – DACLIZUMAB - MYCOPHENOLATE MOFETIL IMMUNE PROPHYLAXIS IN PEDIATRIC LIVER TRANSPLANTATION. An open, pilot, investigator-driven study in 20 recipients bad-data
Ongoing 2007-003223-20 Temocillin use in intensive care units: A Pharmacokinetic study of 6g per day in conventional administration vs. continuous infusion not-yet-due
Ongoing, reported early 2007-004694-26 A Comparative Study Of A 6-Month Infliximab (Remicade) Or Placebo Regimen In Undifferentiated Arthritis At High Risk For The Development Of Rheumatoid Arthritis : Clinical, Radiological (MRI) And Syno... not-yet-due
Ongoing 2007-004911-79 Pharmacodynamics of Fondaparinux subcutaneous versus continuous intravenous infusion in critically ill patients with or without vasopressors. not-yet-due
Exempt, with results 2008-001354-41 Neoadjuvant cetuximab monotherapy followed by surgery in squamous cell carcinoma of head and neck: phase I/II study not-yet-due
Ongoing 2008-003167-39 Effet du fluconazole sur le taux d'anticorps anti-Saccharomyces cerevisiae (ASCSA) après résection chirurgicale pour maladie de Crohn. not-yet-due
Ongoing, reported early 2008-004575-21 A single arm, multicenter, phase II trial of RAD001 as monotherapy in the palliative treatment of patient with locally advanced or metastatic transitional cell carcinoma after failure of platinum-base... not-yet-due
Reported results 2008-004707-59 A phase II study of CP-751,871 in patients with recurrent and/or metastatic squamous head and neck carcinoma 2009-12-03 due-trials
Completed, but no date 2008-008720-33 A one year, open, prospective study on the role of quarterly intravitreal injections of Lucentis 0,5 mg (ranibizumab) in preventing of delaying progression of radiation retinopathy in eyes treated wit... bad-data
Reported results 2009-010759-29 étude clinique sur l’administration de 3 doses de betaméthasone (12mg) à 18 heures d’intervalle lors d’une menace d’accouchement prématuré dans les grossesses gémellaires traitées par Atosiban, plutôt... 2016-07-26 due-trials
Completed, but no date, and reported results Terminated 2009-011325-14 Phase II Study of Preoperative Panitumumab and External Beam Radiotherapy in Patients with Locally Advanced Rectal Cancer bad-data
Reported results 2009-015237-76 An open label multicentric phase II study of Panitumumab (Vectibix®) in cutaneous squamous cell carcinoma (SCC) 2017-01-17 due-trials
Exempt, with results 2010-018638-29 Phase I/II study of peptide vaccination associated with GM-CT-01, a galactomannan oligomer that inhibits galestin-3, in patients with advanced metastatic melanoma not-yet-due
Reported results 2010-019873-13 Comparative study of the clinical response and cardiorespiratory endurance in early rheumatoid arthritis patients treated with Tociluzimab or Methotrexate Addendum protocol : Global gene expression pr... 2013-09-16 due-trials
Completed, but no date, and reported results Terminated 2010-019983-35 Phase I-II study of low dose CdA combined with valproic acid (VPA) in previously treated B-cell chronic lymphocytic leukemia (CLL) patients. bad-data
Ongoing 2011-001756-12 Surrogate markers evaluation in pre-demented Alzheimer’s disease patients and healthy elderly controls not-yet-due
Completed, but no date, and reported results 2011-001938-42 Randomized Phase II Study of CABAZITAXEL versus METHOTREXATE in patients with recurrent or metastatic squamous cell carcinoma of the head and neck previously treated with platinum-based therapy Etu... bad-data
Ongoing 2011-003124-12 A prospective phase II study on dose escalation using PET based adaptive IMRT stage II-III non small lung cancer not-yet-due
Ongoing, reported early 2011-005174-27 Phase II study of High-Dose Rituximab in High Risk Chronic Lymphocytic Leukemia in Suboptimal Response after Induction Immunochemotherapy not-yet-due
Not reported 2011-005274-30 Efficacy and safety of a Double Icodextrin Dose in elderly incident CAPD patients on incremental Peritoneal Dialysis therapy: the DIDo study 2020-02-28 due-trials
Completed, reported early 2011-006085-40 A proof of concept study to evaluate the use of metabonomics and lipidomics in predicting toxicity and efficacy of anti-VEGF therapy in patients with metastatic clear cell renal cell carcinoma. 2020-10-15 not-yet-due
Ongoing 2012-003314-13 RING ? RItuximab for lupus Nephritis with remission as a Goal, an investigator-initiated randomized international open multicentric study Rituximab para la remisión de la nefritis lúpica. Estudio i... not-yet-due
Reported results 2012-003774-76 Perioperative ketorolac in high risk breast cancer patients with and without inflammation. A prospective randomized placebo-controlled trial. 2015-10-01 due-trials
Completed, but no date, and reported results Terminated 2012-004123-20 A single arm, multicenter, phase II study of BEZ235 as monotherapy in patients with locally advanced or metastatic Transitional Cell Carcinoma (TCC) after failure of platinum based chemotherapy. Et... bad-data
Ongoing, reported early 2012-005076-34 Prolonged-release oral Fampridine in Multiple Sclerosis: effects on clinical, neurophysiological and quantified gait analysis parameters. A cross-over, double-blinded, placebo-controlled study. Fa... not-yet-due
Completed, but no date, and reported results Terminated 2012-005249-19 Randomized Phase 2 study comparing pathological responses observed on colorectal cancer metastases resected after preoperative treatment combining cetuximab with FOLFOX or FOLFIRI in RAS and B-RAF WT ... bad-data
Ongoing 2012-005376-34 Randomized Phase 2 study comparing pathological responses observed on colorectal cancer metastases resected after preoperative treatment combining bevacizumab with FOLFOX or FOLFIRI. Etude randomis... not-yet-due
Ongoing 2013-000615-24 Tacrolimus disposition in pediatric transplantation: influence of age, genetic polymorphisms, intestinal and hepatic relative contribution on pharmacokinetics, in relationship with clinical outcomes ... not-yet-due
Completed, but no date, and reported results Terminated 2014-003856-30 Sandostatin (Octreotide LAR) may lead to clinical improvement through receptor occupation optimisation. A prospective interventional trial of patients with neuro-endocrine tumors with carcinoid syndro... bad-data
Ongoing 2014-004224-22 Temocillin pharmacokinetics in paediatrics Pharmacocinétique de la témocilline en pédiatrie not-yet-due
Completed, but no date, and reported results 2014-005170-11 Can we get conscious sedation in optimal safety conditions in an emergency department, by combining dexmedetomidine with alfentanil? Peut-on obtenir une sédation consciente, dans des conditions opt... bad-data
Ongoing 2015-001246-28 Ultrasound scores as imaging biomarkers of early response to subcutaneous tocilizumab in association with methotrexate in early rheumatoid arthritis (TOVERA study) not-yet-due
Ongoing 2015-001703-32 Phase III multicentric study evaluating the efficacy and safety of sirolimus in Vascular Anomalies that are refractory to standard care not-yet-due
Ongoing 2015-003146-75 A multi-centre randomized, placebo-controlled trial of mirabegron, a new beta3-adrenergic receptor agonist on the progression of left ventricular mass and diastolic function in patients with structura... not-yet-due
Reported results 2016-005062-61 Effects of vitamin D supplementation during a non-surgical treatment of generalized chronic periodontitis: a randomized double-blinded placebo-controlled clinical trial 2018-09-22 due-trials
Completed, but no date, and reported results Terminated 2017-001619-35 Exploratory pathophysiological study in five patients suffering from new-onset lupus nephritis and treated with rituximab as first-line treatment Etude physiopathologique exploratoire chez cinq pat... bad-data
Ongoing, reported early 2017-002007-97 Does LOW Dose DEXmedetomidine After Cardiopulmonary Bypass Separation Decrease the Incidence of DELirium: A Double-blind Randomized Placebocontrolled Study (LOWDEXDEL Study) not-yet-due
Ongoing 2017-002473-19 PREDICTIVE FACTORS AND MAGNITUDE OF RESPONSE TO OMALIZUMAB AND MEPOLIZUMAB IN ALLERGIC AND EOSINOPHILIC SEVERE ASTHMA: A MULTICENTER PRAGMATIC TRIAL IN BELGIUM not-yet-due
Ongoing 2017-002532-16 Adjunctive systemic antimicrobial therapy in the surgical treatment of peri-implantitis. A prospective randomized clinical study not-yet-due
Completed, but no date, and reported results 2017-003406-40 Repetitive blood donations and endurance sport performance: does iron supplementation limit the negative effects on hematological parameters? Dons de sang répétés et performance en endurance: est-c... bad-data
Ongoing 2017-004058-40 A multicentre, open-label, three-arm randomised Phase II trial assessing the safety and efficacy of the HSP90 inhibitor Ganetespib in combination with Carboplatin followed by maintenance treatment wit... not-yet-due
Ongoing 2017-004493-34 Evaluation of multiple subgingival irrigations with 10% povidone iodine after scaling and root planing : a randomized clinical trial not-yet-due
Ongoing 2018-001096-20 Avelumab combined with cetuximab and irinotecan for treatment refractory metastatic colorectal microsatellite stable cancer – A proof of concept, open label non-randomized Phase IIa study. not-yet-due
Ongoing 2018-002499-42 Evaluation of the effect of repeated injections of high doses of botulinum toxin into the lower limb of spastic brain lesions on functional and biomechanical parameters of walking Évaluation de l’e... not-yet-due
Ongoing 2018-004191-35 Evaluation of the safety and efficacy of administration of Empagliflozin in a new treatment for neutropenia in patients with Glycogen Storage Disease type 1b (GSD1b) and G6PC3 deficiency. Évaluati... not-yet-due
Ongoing 2019-000572-41 An open label phase II study combining Nivolumab and Celecoxib in patients with advanced « cold » solid tumors not-yet-due
Ongoing 2019-001204-37 A randomized, double-blind, placebo-controlled, cross-over, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin and tapentadol on biomarkers of pain processing ... not-yet-due
No trial status on register 2019-003573-26 Monocentric pilot trial evaluating efficacy of Trametinib in Arteriovenous Malformations that are refractory to standard treatments or for which standard treatment are contra-indicated bad-data